Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bone Marrow Transplantation

  Free Subscription

Articles published in
Am J Hematol
    April 2024
  1. EAPEN M, Kou J, Andreansky M, Bhatia M, et al
    Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
    Am J Hematol. 2024;99:785-788.
    >> Share

    February 2024
  2. AHMED S, Bashir Q, Bassett RL Jr, Ullah F, et al
    Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
    Am J Hematol. 2024 Feb 5. doi: 10.1002/ajh.27233.
    >> Share

    January 2024
  3. BARON F, Efficace F, Cannella L, Stevens-Kroef M, et al
    Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.
    Am J Hematol. 2024 Jan 4. doi: 10.1002/ajh.27196.
    >> Share

    September 2023
  4. VON ASMUTH EGJ, Lankester AC, Putter H
    Chronic GvHD in a prognostic model: Graft versus leukemia predictor or immortal time bias?
    Am J Hematol. 2023 Sep 15. doi: 10.1002/ajh.27083.
    >> Share

    March 2023
  5. FORNI GL, Gianesin B, Musallam KM, Longo F, et al
    Overall and complication-free survival in a large cohort of patients with beta-thalassemia major followed over 50 years.
    Am J Hematol. 2023;98:381-387.
    >> Share

    January 2023
  6. GURU MURTHY GS, Logan BR, Bo-Subait S, Beitinjaneh A, et al
    Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
    Am J Hematol. 2023 Jan 6. doi: 10.1002/ajh.26834.
    >> Share

    June 2022
  7. BARON F, Labopin M, Tischer J, Ciceri F, et al
    Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients >/=55 years of age.
    Am J Hematol. 2022 Jun 13. doi: 10.1002/ajh.26627.
    >> Share

  8. MOHAN M, Gundarlapalli S, Szabo A, Yarlagadda N, et al
    Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
    Am J Hematol. 2022;97:E195-E198.
    >> Share

    September 2021
  9. PETIT AF, Kulasekararaj AG, Eikema DJ, Maschan A, et al
    Upfront unrelated donor Hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: a retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation.
    Am J Hematol. 2021 Sep 22. doi: 10.1002/ajh.26354.
    >> Share

    February 2021
  10. ZUBICARAY J, Pagliara D, Sevilla J, Eikema DJ, et al
    Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: results from the Severe Aplastic Anemia Working Party of the EBMT.
    Am J Hematol. 2021 Feb 19. doi: 10.1002/ajh.26135.
    >> Share

  11. DEVINE SM
    Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the Covid-19 pandemic: A National Marrow Donor Program perspective.
    Am J Hematol. 2021;96:169-171.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016